Home Biomarkers Direct Bilirubin

Direct Bilirubin

LFT Biomarker

Sample Needed

Collection Type: Blood

Body System

Related System: LFT

Overview

Direct bilirubin (conjugated bilirubin) is the water‑soluble form of bilirubin produced when the liver adds glucuronic acid to unconjugated bilirubin so it can be excreted in bile. The direct bilirubin test measures the conjugated fraction in blood and helps distinguish liver excretory problems from increased bilirubin production. Elevated direct bilirubin suggests impaired bile flow or hepatocellular excretion (obstruction from gallstones, cholestasis, biliary strictures, drug‑induced cholestasis) or certain genetic syndromes. Symptoms prompting testing include jaundice, dark urine, pale stools, itching, abdominal pain, and unexplained fatigue. Newborns typically have higher unconjugated bilirubin; otherwise age and sex cause only small differences, though pregnancy and older age increase risk of cholestatic conditions.

People also test for

Test Preparation

No special preparation is required

Why Do I Need This Test

Profile: Included in the LFT (Liver Function Test) panel.
Symptoms: Jaundice, dark urine, pale stools, pruritus, abdominal pain or acute liver dysfunction.
Diagnoses/monitoring: Detects/monitors obstructive jaundice, intrahepatic cholestasis, hepatitis, cirrhosis, and certain genetic conjugation/excretion disorders.
Reasons for abnormal levels: Bile duct obstruction, hepatocellular injury, drug‑induced cholestasis, or genetic transport defects.
Biological meaning: Elevated direct bilirubin means conjugated bilirubin is accumulating because it cannot be excreted into bile.
Behaviors: Heavy alcohol use, certain medications, obesity, and poor metabolic health can contribute.
Family history: Inherited disorders (e.g., Dubin‑Johnson, Rotor syndrome) or familial cholestatic disease warrant testing.

Run our symptom checker to see if this test is right for you

Symptom Checker

Understanding Test Results

Values ≤0.3 mg/dL (≤5 μmol/L) are normal.
Mild elevations (≈0.3–2.0 mg/dL or ~5–34 μmol/L) may indicate early or mild cholestasis, acute hepatitis with impaired excretion, partial bile duct obstruction, or chronic liver disease.
Moderate elevations (≈2.0–5.0 mg/dL or ~34–85 μmol/L) suggest more significant biliary obstruction (e.g., stones, strictures), progressive cholestasis, or advanced hepatocellular injury.
Marked elevations (>5.0 mg/dL or >85 μmol/L) usually reflect major obstructive processes or severe liver dysfunction and require prompt evaluation.
Isolated rise in direct bilirubin (with normal unconjugated bilirubin) points to post‑hepatic or intrahepatic excretory problems; by contrast, high total with normal direct suggests predominantly unconjugated causes (hemolysis, Gilbert).
Conjugated bilirubin is water‑soluble and typically appears in urine when elevated, producing dark urine.

Normal Range

0.0-0.3 mg/dL OR 0-5 μmol/L

FAQs

Q: What happens when direct bilirubin is high?

A: High direct (conjugated) bilirubin indicates impaired bilirubin excretion by the liver or bile ducts. Common causes include bile-duct obstruction (stones, tumors), cholestatic liver disease, hepatitis, or drug-induced cholestasis. It causes jaundice, dark urine, pale stools and itching. Elevated direct bilirubin warrants further evaluation with liver tests, imaging and sometimes urgent referral to identify and treat underlying hepatobiliary disease.

Q: How do you reduce direct bilirubin?

A: Reduce conjugated (direct) bilirubin by treating the underlying cause: relieve biliary obstruction (ERCP, stone removal, stent or surgery), treat infections (antibiotics for cholangitis), and manage liver disease (antivirals for hepatitis, ursodeoxycholic acid for cholestatic disorders). Supportive measures include stopping alcohol/hepatotoxic drugs, optimizing nutrition and hydration, and close follow‑up with a hepatologist.

Q: Is direct bilirubin normal range?

A: Direct (conjugated) bilirubin is normally about 0–0.3 mg/dL (0–5.1 µmol/L), though specific laboratory reference ranges can vary slightly. Levels above the upper limit suggest impaired bilirubin excretion from the liver or bile ducts (cholestasis) or hepatocellular injury and warrant clinical evaluation with further tests. Discuss abnormal results with your healthcare provider.

Q: What is indirect bilirubin?

A: Indirect bilirubin (unconjugated bilirubin) is the lipid‑soluble form produced when heme from aged red blood cells is broken down. It travels bound to albumin to the liver for enzymatic conjugation, becoming water‑soluble for excretion. It is not excreted in urine. Elevated levels occur with increased hemolysis, impaired hepatic conjugation (e.g., Gilbert’s syndrome), or neonatal liver immaturity.

Q: Why is direct bilirubin high in liver disease?

A: Direct (conjugated) bilirubin rises in liver disease because the liver can’t properly excrete conjugated bilirubin into bile. Hepatocellular injury or intrahepatic/extrahepatic cholestasis impairs uptake, canalicular transporter function, or blocks bile ducts, causing conjugated bilirubin to accumulate and spill back into blood (and urine). Impaired bile secretion or flow, not increased bilirubin production, raises direct bilirubin.

Q: Can dehydration cause high direct bilirubin?

A: Dehydration can cause mild rises in total bilirubin through hemoconcentration or reduced hepatic blood flow, but isolated elevation of direct (conjugated) bilirubin usually points to liver or bile-duct problems (cholestasis, obstruction, hepatitis). Only severe hypovolemia or ischemic liver injury would be expected to raise conjugated bilirubin. Persistent or high direct bilirubin should prompt medical evaluation and liver testing/imaging.